Nano Let‑7b sensitization of eliminating esophageal cancer stem‑like cells is dependent on blockade of Wnt activation of symmetric division

Pang,Yamei; Liu,Jian; Li,Xiang; Zhang,Yiwen; Zhang,Boxiang; Zhang,Jing; Du,Ning; Xu,Chongwen; Liang,Rui; Ren,Hong; Tang,Shou-Ching; Sun,Xin

doi:10.3892/ijo.2017.4104

Nano Let‑7b sensitization of eliminating esophageal cancer stem‑like cells is dependent on blockade of Wnt activation of symmetric division

Authors:
- Yamei Pang
- Jian Liu
- Xiang Li
- Yiwen Zhang
- Boxiang Zhang
- Jing Zhang
- Ning Du
- Chongwen Xu
- Rui Liang
- Hong Ren
- Shou-Ching Tang
- Xin Sun
View Affiliations

Affiliations: Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China, Department of Thoracic Surgery and Oncology, The Second Department of Thoracic Surgery, Cancer Center, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China, Department of Cardiothoracic Surgery, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710004, P.R. China, Department of Otorhinolaryngology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China, Department of Hepatobiliary Chest Surgery, Shaanxi Provincial Corps Hospital of Chinese People's Armed Police Force, Xi'an, Shaanxi 710066, P.R. China, Georgia Cancer Center, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA
Published online on: August 29, 2017 https://doi.org/10.3892/ijo.2017.4104
Pages: 1077-1088
Copyright: © Pang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The poor therapy response and poor prognosis of esophageal cancer has made it one of the most malignant carcinoma, and the complicated multidisciplinary treatment failed to achieve a long-term disease-free survival. To diagnose esophageal cancer at an earlier stage, and to improve the effect of anticancer therapy would improve the therapeutic efficacy. After retrospective analysis of the cancer samples of patients who received esophagectomy, we found the relevance between ratio of either ALDH1 or CD133-positive cancer stem cells and 2-year recurrence. Higher ratios of cancer stem cells indicated later clinical stages, and Wnt signaling activation was more frequent in later esophageal carcinoma. Further in bench studies, we explored the suppressive roles and the mechanisms involved in Let‑7 on self-renewal in ECA‑109 and ECA‑9706 esophageal cancer stem cells. Isolated cancer stem cells naturally divide symmetrically and are therapy resistant. Therapy of fluorouracil and docetaxel both enriched the stem cells, proving the resistant characteristics of cancer stem cells. Wnt activation stimulated more symmetric division of stem cells, resulting in self-renewal promotion, which could be blocked by Let‑7 overexpression. Furthermore, enforced Let‑7 sensitized the stem cells to chemotherapies in a Wnt pathway inhibition-dependent manner, contributing to Let‑7 sensitization of chemotherapeutic response. Wnt activation weakened the suppressive Let‑7b through the sponge functions of CCAT-1, forming the negative feedback loop of Let‑7b/Wnt/CCAT1. These results identified the crucial participation of stem cells in esophageal cancer occurrence and progression as the potent indicator, and also indicate the potential powerful agent of Let‑7 nano-particles in treatment of cancer.

View Figures

View References

1	Rustgi AK and El-Serag HB: Esophageal carcinoma. N Engl J Med. 371:2499–2509. 2014. View Article : Google Scholar : PubMed/NCBI
2	Pennathur A, Gibson MK, Jobe BA and Luketich JD: Oesophageal carcinoma. Lancet. 381:400–412. 2013. View Article : Google Scholar : PubMed/NCBI
3	Song Y, Li L, Ou Y, Gao Z, Li E, Li X, Zhang W, Wang J, Xu L, Zhou Y, et al: Identification of genomic alterations in oesophageal squamous cell cancer. Nature. 509:91–95. 2014. View Article : Google Scholar : PubMed/NCBI
4	Sun X, Liu J, Xu C, Tang SC and Ren H: The insights of Let-7 miRNAs in oncogenesis and stem cell potency. J Cell Mol Med. 20:1779–1788. 2016. View Article : Google Scholar : PubMed/NCBI
5	Sun X, Jiao X, Pestell TG, Fan C, Qin S, Mirabelli E, Ren H and Pestell RG: MicroRNAs and cancer stem cells: The sword and the shield. Oncogene. 33:4967–4977. 2014. View Article : Google Scholar
6	Wan L, Zhang L, Fan K, Cheng ZX, Sun QC and Wang JJ: Circular RNA-ITCH suppresses lung cancer proliferation via inhibiting the Wnt/β-catenin pathway. BioMed Res Int. 2016:15794902016. View Article : Google Scholar
7	Blagodatski A, Poteryaev D and Katanaev VL: Targeting the Wnt pathways for therapies. Mol Cell Ther. 2:282014. View Article : Google Scholar : PubMed/NCBI
8	Dhar SK, Tangpong J, Chaiswing L, Oberley TD and St Clair DK: Manganese superoxide dismutase is a p53-regulated gene that switches cancers between early and advanced stages. Cancer Res. 71:6684–6695. 2011. View Article : Google Scholar : PubMed/NCBI
9	Hirsch HA, Iliopoulos D and Struhl K: Metformin inhibits the inflammatory response associated with cellular transformation and cancer stem cell growth. Proc Natl Acad Sci USA. 110:972–977. 2013. View Article : Google Scholar : PubMed/NCBI
10	Zhou D, Shao L and Spitz DR: Reactive oxygen species in normal and tumor stem cells. Adv Cancer Res. 122:1–67. 2014. View Article : Google Scholar : PubMed/NCBI
11	Printz C: Radiation treatment generates therapy-resistant cancer stem cells from less aggressive breast cancer cells. Cancer. 118:3225. 2012.PubMed/NCBI
12	Deng L, Yang S-B, Xu F-F and Zhang J-H: Long noncoding RNA CCAT1 promotes hepatocellular carcinoma progression by functioning as let-7 sponge. J Exp Clin Cancer Res. 34:182015. View Article : Google Scholar : PubMed/NCBI
13	Sun X, Xu C, Tang SC, Wang J, Wang H, Wang P, Du N, Qin S, Li G, Xu S, et al: Let-7c blocks estrogen-activated Wnt signaling in induction of self-renewal of breast cancer stem cells. Cancer Gene Ther. 23:83–89. 2016. View Article : Google Scholar : PubMed/NCBI
14	Beck B and Blanpain C: Unravelling cancer stem cell potential. Nat Rev Cancer. 13:727–738. 2013. View Article : Google Scholar : PubMed/NCBI
15	Taylor MD, Poppleton H, Fuller C, Su X, Liu Y, Jensen P, Magdaleno S, Dalton J, Calabrese C, Board J, et al: Radial glia cells are candidate stem cells of ependymoma. Cancer Cell. 8:323–335. 2005. View Article : Google Scholar : PubMed/NCBI
16	Atkinson RL, Yang WT, Rosen DG, Landis MD, Wong H, Lewis MT, Creighton CJ, Sexton KR, Hilsenbeck SG, Sahin AA, et al: Cancer stem cell markers are enriched in normal tissue adjacent to triple negative breast cancer and inversely correlated with DNA repair deficiency. Breast Cancer Res. 15:R772013. View Article : Google Scholar : PubMed/NCBI
17	Hang D, Dong HC, Ning T, Dong B, Hou DL and Xu WG: Prognostic value of the stem cell markers CD133 and ABCG2 expression in esophageal squamous cell carcinoma. Dis Esophagus. 25:638–644. 2012. View Article : Google Scholar : PubMed/NCBI
18	Zhu Y, Luo M, Brooks M, Clouthier SG and Wicha MS: Biological and clinical significance of cancer stem cell plasticity. Clin Transl Med. 3:322014. View Article : Google Scholar : PubMed/NCBI
19	Zhang Y, Molavi O, Su M and Lai R: The clinical and biological significance of STAT1 in esophageal squamous cell carcinoma. BMC Cancer. 14:7912014. View Article : Google Scholar : PubMed/NCBI
20	Zhang G, Ma L, Xie YK, Miao XB and Jin C: Esophageal cancer tumorspheres involve cancer stem-like populations with elevated aldehyde dehydrogenase enzymatic activity. Mol Med Rep. 6:519–524. 2012. View Article : Google Scholar : PubMed/NCBI
21	Yang L, Ren Y, Yu X, Qian F, Bian BS, Xiao HL, Wang WG, Xu SL, Yang J, Cui W, et al: ALDH1A1 defines invasive cancer stem-like cells and predicts poor prognosis in patients with esophageal squamous cell carcinoma. Mod Pathol. 27:775–783. 2014. View Article : Google Scholar
22	Rodriguez-Torres M and Allan AL: Aldehyde dehydrogenase as a marker and functional mediator of metastasis in solid tumors. Clin Exp Metastasis. 33:97–113. 2016. View Article : Google Scholar :
23	Hwang C-C, Nieh S, Lai C-H, Tsai CS, Chang LC, Hua CC, Chi WY, Chien HP, Wang CW, Chan SC, et al: A retrospective review of the prognostic value of ALDH-1, Bmi-1 and Nanog stem cell markers in esophageal squamous cell carcinoma. PLoS One. 9:e1056762014. View Article : Google Scholar : PubMed/NCBI
24	Dey-Guha I, Wolfer A, Yeh AC, G Albeck J, Darp R, Leon E, Wulfkuhle J, Petricoin EF III, Wittner BS and Ramaswamy S: Asymmetric cancer cell division regulated by AKT. Proc Natl Acad Sci USA. 108:12845–12850. 2011. View Article : Google Scholar : PubMed/NCBI
25	Cicalese A, Bonizzi G, Pasi CE, Faretta M, Ronzoni S, Giulini B, Brisken C, Minucci S, Di Fiore PP and Pelicci PG: The tumor suppressor p53 regulates polarity of self-renewing divisions in mammary stem cells. Cell. 138:1083–1095. 2009. View Article : Google Scholar : PubMed/NCBI
26	Gómez-López S, Lerner RG and Petritsch C: Asymmetric cell division of stem and progenitor cells during homeostasis and cancer. Cell Mol Life Sci. 71:575–597. 2014. View Article : Google Scholar :
27	Fürthauer M and González-Gaitán M: Endocytosis, asymmetric cell division, stem cells and cancer: Unus pro omnibus, omnes pro uno. Mol Oncol. 3:339–353. 2009. View Article : Google Scholar : PubMed/NCBI
28	El-Hashash AHK and Warburton D: Numb expression and asymmetric versus symmetric cell division in distal embryonic lung epithelium. J Histochem Cytochem. 60:675–682. 2012. View Article : Google Scholar : PubMed/NCBI
29	Kechad A, Jolicoeur C, Tufford A, Mattar P, Chow RWY, Harris WA and Cayouette M: Numb is required for the production of terminal asymmetric cell divisions in the developing mouse retina. J Neurosci. 32:17197–17210. 2012. View Article : Google Scholar : PubMed/NCBI
30	Martin-Blanco NM, Checquolo S, Del Gaudio F, Palermo R, Franciosa G, Di Marcotullio L, Gulino A, Canelles M and Screpanti I: Numb-dependent integration of pre-TCR and p53 function in T-cell precursor development. Cell Death Dis. 5:e14722014. View Article : Google Scholar : PubMed/NCBI
31	Brand AH: A new dawn for Aurora? Nat Cell Biol. 10:1253–1254. 2008. View Article : Google Scholar : PubMed/NCBI
32	Landen CN Jr, Chavez-Reyes A, Bucana C, Schmandt R, Deavers MT, Lopez-Berestein G and Sood AK: Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery. Cancer Res. 65:6910–6918. 2005. View Article : Google Scholar : PubMed/NCBI
33	Seviour EG, Sehgal V, Mishra D, Rupaimoole R, Rodriguez-Aguayo C, Lopez-Berestein G, Lee J-S, Sood AK, Kim MP, Mills GB, et al: Targeting KRas-dependent tumour growth, circulating tumour cells and metastasis in vivo by clinically significant miR-193a-3p. Oncogene. 36:1339–1350. 2017. View Article : Google Scholar
34	Rupaimoole R, Ivan C, Yang D, Gharpure KM, Wu SY, Pecot CV, Previs RA, Nagaraja AS, Armaiz-Pena GN, McGuire M, et al: Hypoxia-upregulated microRNA-630 targets Dicer, leading to increased tumor progression. Oncogene. 35:4312–4320. 2016. View Article : Google Scholar : PubMed/NCBI
35	Sun X, Jiang S, Liu J, Wang H, Zhang Y, Tang SC, Wang J, Du N, Xu C, Wang C, et al: MiR-208a stimulates the cocktail of SOX2 and β-catenin to inhibit the let-7 induction of self-renewal repression of breast cancer stem cells and formed miR208a/let-7 feedback loop via LIN28 and DICER1. Oncotarget. 6:32944–32954. 2015. View Article : Google Scholar : PubMed/NCBI
36	Hwang W-L, Jiang J-K, Yang S-H, Huang TS, Lan HY, Teng HW, Yang CY, Tsai YP, Lin CH, Wang HW, et al: MicroRNA-146a directs the symmetric division of Snail-dominant colorectal cancer stem cells. Nat Cell Biol. 16:268–280. 2014. View Article : Google Scholar : PubMed/NCBI
37	Lathia JD, Hitomi M, Gallagher J, Gadani SP, Adkins J, Vasanji A, Liu L, Eyler CE, Heddleston JM, Wu Q, et al: Distribution of CD133 reveals glioma stem cells self-renew through symmetric and asymmetric cell divisions. Cell Death Dis. 2:e2002011. View Article : Google Scholar : PubMed/NCBI
38	Todaro M, Francipane MG, Medema JP and Stassi G: Colon cancer stem cells: Promise of targeted therapy. Gastroenterology. 138:2151–2162. 2010. View Article : Google Scholar : PubMed/NCBI
39	Morrison SJ and Kimble J: Asymmetric and symmetric stem-cell divisions in development and cancer. Nature. 441:1068–1074. 2006. View Article : Google Scholar : PubMed/NCBI
40	Berika M, Elgayyar ME and El-Hashash AHK: Asymmetric cell division of stem cells in the lung and other systems. Front Cell Dev Biol. 2:332014. View Article : Google Scholar : PubMed/NCBI